Vaccinex, Inc.
ANTI-CXCL13 ANTIBODIES AND METHODS OF USING THE SAME
Last updated:
Abstract:
Compositions and methods are provided for treating diseases associated with CXCL13 expression, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CXCL13 monoclonal antibodies have been developed to neutralize CXCL13.
Status:
Application
Type:
Utility
Filling date:
24 Sep 2020
Issue date:
25 Mar 2021